LONDON, 5 August, 2021 — Madison International Realty, a leading real estate private equity firm, announces that it has invested in AXA IM Alts European Life Sciences platform. Following the investment, Madison owns a minority stake in, and has advisory participation of, Kadans Science Partner, which AXA IM Alts acquired in December 2020.
Madison believes the investment will allow Kadans to further progress its strategy for growth in Europe by undertaking new acquisition opportunities and continuing to build out its existing development opportunities.
The investment is Madison’s first in the European life sciences sector and follows a $200m commitment made to IQHQ, a US life sciences real estate owner, operator and developer, during 2020.
Kadans is a fully integrated developer, owner and operator of European science parks and lab offices with a defined focus and scale. Its portfolio currently comprises c. 167,000 sqm of operating space across 22 assets in key research locations in the Netherlands, UK and Germany, as well as eight developments which are estimated to deliver c.120,000 sqm of new space by 2024.
A key element of Kadans’ success has been the creation of innovation ecosystems not just within the individual building and campuses it operates in, but across its whole network of tenants and relationships across Europe. By promoting networking, connectivity and events management for tenants, public bodies and academic institutions, Kadans is able to help enhance information flow and knowledge sharing1.
Alex Lukesch, Managing Director at Madison International Realty commented on the investment: “Through this investment we have secured a stake in a developer and operator of life sciences real estate in Europe. Life sciences is a sector which we are already active in in the US but is still relatively new in Europe, and could be poised for further growth. The transaction is in line with our broader strategy of both investing where we have strong conviction and of taking stakes with what we believe are best in class operators, properties and businesses and working alongside highly regarded managers in sectors that we believe have the potential to grow significantly.”
ENDS
1https://realassets.axa-im.com/content/-/asset_publisher/x7LvZDsY05WX/content/axa-im-alts-raises-e2-82-ac1.9-billion-for-european-life-sciences-investments/24669
About Madison International Realty
Madison International Realty (www.madisonint.com) is a leading liquidity provider to real estate investors worldwide. Madison provides equity capital for real estate owners and investors seeking to monetize embedded equity, to replace capital partners seeking an exit and to recapitalize balance sheets. The firm provides equity for recapitalizations, partner buyouts and capital infusions; and acquires joint venture, limited partner and co-investment interests as principals. Madison invests in secondary transactions and focuses on existing properties and portfolios in the U.S., U.K., and Europe. Madison has offices in New York, London, Amsterdam, Luxembourg and Frankfurt, where the firm operates under the name of Madison International Realty GmbH.
Contact:
Madison International Realty
Richard Sunderland/Claire Turvey/Andrew Davis (UK/Europe)
FTI Consulting Inc
Email: [email protected]
Phone: +44 (0)203 727 1000
Michelle Manoff
(US)
Rubenstein Public Relations
Email: [email protected]
Phone +1 212-805-3051